BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rolston KV, Nesher L, Tarrand JT. Current Microbiology of Surgical Site Infections in Patients with Cancer: A Retrospective Review. Infect Dis Ther 2014;3:245-56. [PMID: 25403432 DOI: 10.1007/s40121-014-0048-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Le Meur N, Grammatico-guillon L, Wang S, Astagneau P. Health insurance database for post-discharge surveillance of surgical site infection following arthroplasty. Journal of Hospital Infection 2016;92:140-6. [DOI: 10.1016/j.jhin.2015.10.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhang H, Wang Y, Yang S, Zhang Y. Peri-Operative Antibiotic Prophylaxis Does Not Reduce Surgical Site Infection in Breast Cancer. Surg Infect (Larchmt) 2020;21:268-74. [PMID: 31697199 DOI: 10.1089/sur.2019.116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
3 Chang JB, Wu H, Wang H, Ma BT, Wang RZ, Wei JJ. Prevalence and antibiotic resistance of bacteria isolated from the cerebrospinal fluid of neurosurgical patients at Peking Union Medical College Hospital. Antimicrob Resist Infect Control 2018;7:41. [PMID: 29568514 DOI: 10.1186/s13756-018-0323-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
4 Rolston KV, Wang W, Nesher L, Smith JR, Rybak MJ, Prince RA. Time-kill determination of the bactericidal activity of telavancin and vancomycin against clinical methicillin-resistant Staphylococcus aureus isolates from cancer patients. Diagnostic Microbiology and Infectious Disease 2017;87:338-42. [DOI: 10.1016/j.diagmicrobio.2016.12.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
5 Ariza-Heredia EJ, Chemaly RF. Update on infection control practices in cancer hospitals. CA Cancer J Clin 2018;68:340-55. [PMID: 29985544 DOI: 10.3322/caac.21462] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
6 O'Connor RÍ, Kiely PA, Dunne CP. The relationship between post-surgery infection and breast cancer recurrence. J Hosp Infect 2020;106:522-35. [PMID: 32800825 DOI: 10.1016/j.jhin.2020.08.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
7 Rolston KV. Infections in Cancer Patients with Solid Tumors: A Review. Infect Dis Ther. 2017;6:69-83. [PMID: 28160269 DOI: 10.1007/s40121-017-0146-1] [Cited by in Crossref: 89] [Cited by in F6Publishing: 77] [Article Influence: 17.8] [Reference Citation Analysis]
8 Rolston KVI, Reitzel R, Vargas-Cruz N, Shelburne SA, Raad II, Prince RA. In vitro activity of tedizolid and comparator agents against clinical Gram-positive isolates recovered from patients with cancer. Diagn Microbiol Infect Dis 2018;91:351-3. [PMID: 29661529 DOI: 10.1016/j.diagmicrobio.2018.03.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
9 Korupalli C, Huang C, Lin W, Pan W, Lin P, Wan W, Li M, Chang Y, Sung H. Acidity-triggered charge-convertible nanoparticles that can cause bacterium-specific aggregation in situ to enhance photothermal ablation of focal infection. Biomaterials 2017;116:1-9. [DOI: 10.1016/j.biomaterials.2016.11.045] [Cited by in Crossref: 88] [Cited by in F6Publishing: 76] [Article Influence: 17.6] [Reference Citation Analysis]
10 Hagihara M, Kusachi S, Kato Y, Yamagishi Y, Niitsuma T, Mikamo H, Takesue Y, Sumiyama Y. Current status of post-operative infections due to antimicrobial-resistant bacteria after digestive tract surgery in Japan: Japan Postoperative Infectious Complications Survey in 2015 (JPICS'15). Surg Today 2020;50:56-67. [PMID: 31399783 DOI: 10.1007/s00595-019-01857-y] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 . Anforderungen an die Infektionsprävention bei der medizinischen Versorgung von immunsupprimierten Patienten : Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2021;64:232-64. [PMID: 33394069 DOI: 10.1007/s00103-020-03265-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Mccutcheon BA, Ubl DS, Babu M, Maloney P, Murphy M, Kerezoudis P, Bydon M, Habermann EB, Parney I. Predictors of Surgical Site Infection Following Craniotomy for Intracranial Neoplasms: An Analysis of Prospectively Collected Data in the American College of Surgeons National Surgical Quality Improvement Program Database. World Neurosurgery 2016;88:350-8. [DOI: 10.1016/j.wneu.2015.12.068] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 6.3] [Reference Citation Analysis]
13 Rolston KVI, Jamal MA, Nesher L, Shelburne SA, Raad I, Prince RA. In vitro activity of ceftaroline and comparator agents against Gram-positive and Gram-negative clinical isolates from cancer patients. Int J Antimicrob Agents 2017;49:416-21. [PMID: 28257904 DOI: 10.1016/j.ijantimicag.2016.12.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
14 Gomila A, Badia JM, Carratalà J, Serra-Aracil X, Shaw E, Diaz-Brito V, Castro A, Espejo E, Nicolás C, Piriz M, Brugués M, Obradors J, Lérida A, Cuquet J, Limón E, Gudiol F, Pujol M; VINCat Colon Surgery Group. Current outcomes and predictors of treatment failure in patients with surgical site infection after elective colorectal surgery. A multicentre prospective cohort study. J Infect 2017;74:555-63. [PMID: 28315721 DOI: 10.1016/j.jinf.2017.03.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
15 Huang G, Huang Q, Zhang G, Jiang H, Lin Z. Point-prevalence surveys of hospital-acquired infections in a Chinese cancer hospital: From 2014 to 2018. J Infect Public Health 2020;13:1981-7. [PMID: 32280033 DOI: 10.1016/j.jiph.2020.03.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Namiecińska E, Sadowska B, Więckowska-szakiel M, Dołęga A, Pasternak B, Grazul M, Budzisz E. Anticancer and antimicrobial properties of novel η 6 - p -cymene ruthenium( ii ) complexes containing a N,S-type ligand, their structural and theoretical characterization. RSC Adv 2019;9:38629-45. [DOI: 10.1039/c9ra08736b] [Cited by in Crossref: 8] [Article Influence: 2.7] [Reference Citation Analysis]
17 Hernaiz-Leonardo JC, Golzarri MF, Cornejo-Juárez P, Volkow P, Velázquez C, Ostrosky-Frid M, Vilar-Compte D. Microbiology of surgical site infections in patients with cancer: A 7-year review. Am J Infect Control 2017;45:761-6. [PMID: 28385464 DOI: 10.1016/j.ajic.2017.02.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
18 Rolston KV, Wang W, Nesher L, Shelburne SA, Prince RA. In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patients. J Antibiot (Tokyo) 2016;69:381-7. [PMID: 26626876 DOI: 10.1038/ja.2015.120] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]